» Articles » PMID: 34766057

Silver Nanoparticle Based Multifunctional Approach for Combating COVID-19

Overview
Journal Sens Int
Date 2021 Nov 12
PMID 34766057
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 is a highly contagious and widespread disease that has strained the global healthcare system to the hilt. Silver nanoparticles (AgNPs) are well known for their potent antimicrobial, antiviral, immunomodulatory and biosensing properties. AgNPs have been found to be potential antiviral agent that act against many deadly viruses and is presumed to be effective against COVID-19. AgNPs can generate free radicals and reactive oxygen species (ROS) leading to apoptosis mediated cell death thereby inhibiting viral infection. The shape and size of AgNPs play an important role in its biomedical applications as alterations may result in variable biological interaction and activity. Herein, we propose that AgNPs can be utilized for effective management of the ongoing COVID-19 pandemic by highlighting the current status of AgNPs in the fight against COVID-19.

Citing Articles

Biogenic silver nanoparticle as an adjuvant in an S1 subunit recombinant vaccine.

de Freitas S, Neto A, Panagio L, Collares T, Seixas F, Sousa F Braz J Microbiol. 2025; .

PMID: 39878824 DOI: 10.1007/s42770-025-01613-0.


Biogenic nanoparticles as a promising drug delivery system.

Abdel-Megeed R Toxicol Rep. 2025; 14:101887.

PMID: 39867515 PMC: 11762933. DOI: 10.1016/j.toxrep.2024.101887.


Aptamer-decorated nanocarriers for viral adsorption: A special look at COVID-19.

Handali S, Rezaei M Mol Ther Nucleic Acids. 2024; 35(3):102310.

PMID: 39281706 PMC: 11401170. DOI: 10.1016/j.omtn.2024.102310.


Chitosan-Based Structural Color Films for Humidity Sensing with Antiviral Effect.

Burak D, Seo D, An H, Jeong S, Lee S, Cho S Nanomaterials (Basel). 2024; 14(4).

PMID: 38392724 PMC: 10892554. DOI: 10.3390/nano14040351.


Advancements of Nanotechnology and Nanomaterials in Environmental and Human Protection for Combatting the COVID-19 During and Post-pandemic Era: A Comprehensive Scientific Review.

Wibowo Y, Ramadan B, Taher T, Khairurrijal K Biomed Mater Devices. 2023; :1-24.

PMID: 37363141 PMC: 10171735. DOI: 10.1007/s44174-023-00086-9.


References
1.
Mori Y, Ono T, Miyahira Y, Nguyen V, Matsui T, Ishihara M . Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res Lett. 2013; 8(1):93. PMC: 3606407. DOI: 10.1186/1556-276X-8-93. View

2.
Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A . Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020; 117(21):11727-11734. PMC: 7260975. DOI: 10.1073/pnas.2003138117. View

3.
Codeluppi L, Venturelli F, Rossi J, Fasano A, Toschi G, Pacillo F . Facial palsy during the COVID-19 pandemic. Brain Behav. 2020; 11(1):e01939. PMC: 7821573. DOI: 10.1002/brb3.1939. View

4.
Auria-Soro C, Nesma T, Juanes-Velasco P, Landeira-Vinuela A, Fidalgo-Gomez H, Acebes-Fernandez V . Interactions of Nanoparticles and Biosystems: Microenvironment of Nanoparticles and Biomolecules in Nanomedicine. Nanomaterials (Basel). 2019; 9(10). PMC: 6835394. DOI: 10.3390/nano9101365. View

5.
Salleh A, Naomi R, Utami N, Mohammad A, Mahmoudi E, Mustafa N . The Potential of Silver Nanoparticles for Antiviral and Antibacterial Applications: A Mechanism of Action. Nanomaterials (Basel). 2020; 10(8). PMC: 7466543. DOI: 10.3390/nano10081566. View